Chemotherapy-Induced Peripheral Neuropathy clinical trials
22 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Self-applied taVNS for CIPN
- VGAIT for Chemotherapy-induced Peripheral Neuropathy
- Scrambler Therapy With Duloxetine-based Usual Care vs Duloxetine-based Usual Care for Chemotherapy-induced Peripheral Neuropathy.
- Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors
- Understanding and Preventing Cortical Mechanisms of Chemotherapy-induced Peripheral Neuropathy
- Relationship Between Great Toe Strength And Symptoms of Chemotherapy-Induced Peripheral Neuropathy (CIPN)
- International CIPN Assessment and Validation Study
- Assessing Effect of Spinal Cord Stimulation on Pain and Quality of Life With Chemotherapy-Induced Peripheral Neuropathy
- A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment
- Scrambler Therapy for Chemotherapy-Induced Peripheral Neuropathy
- Exploring the Benefit of Peripheral Nerve Stimulation in Treating Pain From Chemo-induced Peripheral Neuropathy: A Longitudinal Single Center Feasibility Study
- Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy
- Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors
- Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT)
- Daily Hand-Held Vibration Therapy
- Evaluating a Mobile Health Application Intervention for Caregiver Instruction in Manual Therapy for Chemotherapy-Induced Peripheral Neuropathy
- SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.
- Intrathecal Ziconotide in Chemotherapy Induced Peripheral Neuropathy
- Neural and Immune Correlates of CIPN and Possible Analgesic Effect of Non-invasive Motor Cortex Stimulation
- Transcranial Direct Current Stimulation for the Treatment of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors
- Helping Cancer Patients Manage Neuropathy Symptoms From Chemotherapy With a Low-Intensity, Low-Risk Cranial PEMF Device
- Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Chemotherapy-Induced Peripheral Neuropathy” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.